Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size More Than Doubles During 2023–2029 to Touch USD 8.44 Billion by 2029

Published | 20 December 2023

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market is flourishing because of the increasing focus on the treatment and management of rising prevalence of diseases and faster and simplified testing.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market size at USD 4.21 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects Global Isothermal Nucleic Acid Amplification Technology Market size to grow at a significant CAGR of 12.29% reaching a value of USD 8.44 billion by 2029. Major growth drivers for the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market include increasing prevalence of infectious diseases. Diseases such as tuberculosis, hepatitis, and influenza are major contributors to fatalities from infectious diseases, particularly in developing nations. Consequently, there is expected growth in the acceptance of INAAT solutions due to the need for swift, easy-to-use, and disease-specific testing alternatives. Ongoing advancements in existing amplification technologies, coupled with the introduction of innovative methods like Single Primer Isothermal Amplification (SPIA), Loop-Mediated Isothermal Amplification (LAMP), Recombinase Polymerase Amplification (RPA), and Strand Displacement Amplification (SDA), are creating new possibilities for INAAT product applications. These developments are expected to enhance the acceptance of the INAAT during the forecast period. Also, prospective strategic collaborations among manufacturers of INAAT diagnostics and related products are poised to play a pivotal role in augmenting market prospects and fostering industry growth. However, complex sample preparation and market competition are anticipated to restrain the overall market growth during the period in analysis.

Opportunity – Innovative applications of INAAT in emerging markets

Emerging applications for Isothermal Nucleic Acid Amplification Technology (INAAT) products result from the rapid evolution of existing amplification technologies and the introduction of innovative methods like Single Primer Isothermal Amplification (SPIA), Loop-Mediated Isothermal Amplification (LAMP), Recombinase Polymerase Amplification (RPA), and Strand Displacement Amplification (SDA). A noteworthy example is a study, published in the Analyst Journal in June 2022, utilizing the LAMP technology to demonstrate swift Zika virus testing with a smartphone-integrated device, requiring only a single blood drop. These advancements are expected to deepen the penetration of the INAAT during the forecast period.

Sample Request @ https://www.blueweaveconsulting.com/report/isothermal-nucleic-acid-amplification-technology-market/report-sample

Impact of Covid-19 on Global Isothermal Nucleic Acid Amplification Technology Market

COVID-19 pandemic had a positive impact on Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market. It led to notable increase in demand for swift and precise testing solutions for the identification of the SARS-CoV-2 (Corona) virus. Various major players in the industry have introduced novel COVID-19 testing products based on INAAT, obtaining emergency use approvals from the US FDA for these products. For instance, commercially available products in this sector encompass Grifols Diagnostic Solutions's Procleix SARS-CoV-2 assay and Lucira Health's Lucira CHECK-IT COVID-19 test kit. Strategic endeavors, prompted by the challenges of the COVID-19 pandemic, are expected to significantly propel market growth during the forecast period.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market – By Application

Based on application, the Global Isothermal Nucleic Acid Amplification Technology Market is divided into Blood Screening, Infectious Disease Diagnostics, and Cancer segments. The infectious disease diagnostics segment holds the highest share in the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market by application. The increasing incidences of infectious diseases, including hepatitis, HIV, herpes, and influenza, along with the efficient diagnosis and treatment facilitated by nucleic acid amplification kits, is expected to propel market expansion. The growing use of point-of-care (PoC) diagnostic tests aids in the early management, treatment, and monitoring of infectious diseases, contributing to market growth. Additionally, heightened awareness and attention towards antimicrobial and epidemic outbreaks are expected to positively influence market growth during the forecast period.

Global Isothermal Nucleic Acid Amplification Technology Market – By Region

The in-depth research report on the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America holds the highest share in the Global Isothermal Nucleic Acid Amplification Technology Market. The region's dominance is attributed to the high prevalence of chronic diseases, technological advancements in INAAT, and a shift towards INAAT over conventional techniques. In 2020, the Centers for Disease Control and Prevention reported around 157 million Americans with chronic diseases. The GLOBOCAN 2020 data revealed 2,281,658 new cancer cases and 612,390 fatalities in the United States. Also, the substantial per capita healthcare expenditure in North America, expected to reach USD 308 billion, further propels market growth. This region is expected to experience continued market expansion.

Competitive Landscape

Major players operating in the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market include Alere, Inc., bioMerieux SA, Eiken Chemical Co. Ltd, Hologic Inc. (Gen-Probe), Meridian Bioscience, Inc., Ustar Biotechnologies Ltd., QIAGEN, Quidel Corporation, Thermo Fisher Scientific, Inc., BD (Becton, Dickinson & Company), and OptiGene Limited. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Don’t miss the business opportunity in the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

About Us

BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.

Contact Us:

BlueWeave Consulting & Research Pvt Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

info@blueweaveconsulting.com